Jazz Pharmaceuticals plc
JAZZ
$167.10
$0.390.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -179.56% | -202.51% | 45.77% | 35.02% | 479.28% |
| Total Depreciation and Amortization | 5.33% | 3.76% | 2.61% | 3.35% | 4.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 365.33% | 479.58% | 13.32% | 3.92% | -56.66% |
| Change in Net Operating Assets | 106.58% | 17.30% | 193.04% | 62.47% | -602.32% |
| Cash from Operations | 19.50% | 22.63% | 50.06% | 27.83% | -8.05% |
| Capital Expenditure | -58.55% | -79.33% | -66.57% | -58.88% | -50.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -134.35% | 120.91% | 10.65% | -237.98% | 68.51% |
| Cash from Investing | -524.58% | -31.20% | 5.79% | -211.66% | 63.83% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -28.88% | -4,274.19% | -4,274.19% | -1,854.84% | -1,854.84% |
| Issuance of Common Stock | 56.98% | 20.77% | 22.84% | -55.56% | -70.04% |
| Repurchase of Common Stock | 56.65% | 10.53% | -18.46% | -15.11% | -110.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,238.31% | -76.53% | -121.79% | 106.72% | 61.42% |
| Foreign Exchange rate Adjustments | 76.15% | 521.42% | 292.60% | -247.32% | -43.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.09% | -325.75% | 51.94% | 45.09% | 77.79% |